Le Lézard
Classified in: Health
Subject: AWD

Synergy Pharmacy Services Earns Industry's Top Quality & Safety Endorsement


PALM HARBOR, Fla., Feb. 23, 2017 /PRNewswire/ -- Synergy Pharmacy Services proudly announces its achievement of PCAB accreditation, a service of Accreditation Commission of Health Care (ACHC), thus joining an elite group of pharmacies nationwide with this distinction. The accreditation demonstrates that Synergy Pharmacy Services meets the highest quality and safety standards in its profession.

To earn PCAB Accreditation, Synergy Pharmacy Services had to complete an extensive application, document its written policies and provide an analysis of its quality procedures that was reviewed by the Pharmacy Compounding Accreditation Board and some of the leading figures in the field of compounding. Next, the pharmacy opened its doors for an extensive on-site inspection led by compounding experts. Only when these stringent evaluations were completed did the Pharmacy Compounding Accreditation Board officially grant Synergy Pharmacy Services the PCAB Seal of Accreditation and the right to use the designation "PCAB Accreditedtm compounding pharmacy." 

"We are honored by this accreditation. It confirms our dedication to protecting our patients by practicing safe, high-quality personalized solutions that address patient's medical needs," said Michael Palso, Synergy Pharmacy Services COO. "We believe this will only further strengthen the bonds of trust between our pharmacy, the patients, and the healthcare providers who rely on us for these specialized medications."

Compounding medications is an integral part of the practice of pharmacy and the demand for these customized medications increases every year. Compounded medications are prescriptions that are written by physicians, veterinarians, and other legally authorized prescribers and prepared for an individual patient by a specially trained pharmacist.

The Pharmacy Compounding Accreditation Board is a not-for-profit corporation formed by eight national pharmacy organizations that recognized the need for a national standards organization for compounding pharmacy. Together, these leading organizations developed the policies and standards for the practice of compounding pharmacy, as well as the PCAB Accreditation criteria and processes.

For more information on PCAB Accreditation, visit the PCAB Web site at www.pcab.org.

Established in 2010, Synergy Pharmacy Services is an award-winning specialty pharmacy. With a focus on pain management, Synergy Pharmacy Services provides compounding, specialty drugs, and retail services to patients nationwide. In addition to the newly appointed PCAB accreditation, Synergy is a proud member of the International Academy of Compounding Pharmacists (IACP), National Association of Boards of Pharmacy, American College of Apothecaries (ACA), and Florida Pharmacy Association (FPA). 

For more information about Synergy Pharmacy Services, Inc, please visit www.synergyrx.com.

Contact: Elizabeth Assad
VP of Special Projects
Phone: 888.918.5024
Email: [email protected]

Related Links

http://www.synergyrx.com

This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com

 

SOURCE Synergy Pharmacy Services, Inc.


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: